NCT02249442View on ClinicalTrials.gov

Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic Insufficiency

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 1, 2003

Primary Completion Date

June 1, 2004

Conditions
Hepatic Insufficiency
Interventions
DRUG

Tipranavir (TPV)

DRUG

Ritonavir (r)

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02249442 - Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic Insufficiency | Biotech Hunter | Biotech Hunter